In Vivo Cell Tracking with Bioluminescence Imaging

被引：106
作者：
Kim J.E. [1 ]
Kalimuthu S. [1 ]
Ahn B.-C. [1 ]
机构：
[1] Department of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, 50, Samduk 2-ga, Jung Gu, Daegu
来源：
Nuclear Medicine and Molecular Imaging | 2015年 / 49卷 / 1期
基金：
新加坡国家研究基金会;
关键词：
Bioluminescence; Cell therapy; Cell tracking; In vivo imaging; Optical imaging;
D O I：
10.1007/s13139-014-0309-x
中图分类号：
学科分类号：
摘要：
Molecular imaging is a fast growing biomedical research that allows the visual representation, characterization and quantification of biological processes at the cellular and subcellular levels within intact living organisms. In vivo tracking of cells is an indispensable technology for development and optimization of cell therapy for replacement or renewal of damaged or diseased tissue using transplanted cells, often autologous cells. With outstanding advantages of bioluminescence imaging, the imaging approach is most commonly applied for in vivo monitoring of transplanted stem cells or immune cells in order to assess viability of administered cells with therapeutic efficacy in preclinical small animal models. In this review, a general overview of bioluminescence is provided and recent updates of in vivo cell tracking using the bioluminescence signal are discussed. © 2014, Korean Society of Nuclear Medicine.
引用
收藏
页码：3 / 10
页数：7
相关论文
共 85 条
  • [61] Koelling S., Miosge N., Stem cell therapy for cartilage regeneration in osteoarthritis, Expert Opin Biol Ther, 9, 11, pp. 1399-1405, (2009)
  • [62] Lee D.S., Optical imaging for stem cell differentiation to neuronal lineage, Nucl Med Mol Imag, 46, 1, pp. 1-9, (2012)
  • [63] Sunwoo M., Yun H., Song S., Ham J., Hong J., Lee J.E., Et al., Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy, Front Aging Neurosci, 6, (2014)
  • [64] Cihova M., Altanerova V., Altaner C., Stem cell based cancer gene therapy, Mol Pharm, 8, 5, pp. 1480-1487, (2011)
  • [65] Devine S.M., Cobbs C., Jennings M., Bartholomew A., Hoffman R., Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood, 101, 8, pp. 2999-3001, (2003)
  • [66] van der Bogt K.E., Sheikh A.Y., Schrepfer S., Hoyt G., Cao F., Ransohoff K.J., Et al., Comparison of different adult stem cell types for treatment of myocardial ischemia, Circulation, 118, pp. S121-S129, (2008)
  • [67] Yang J.J., Liu Z.Q., Zhang J.M., Wang H-b H.S.Y., Liu J.F., Et al., Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart, Heart Vessel, 28, 3, pp. 385-396, (2013)
  • [68] Cao F., Wagner R.A., Wilson K.D., Xie X., Fu J.-D., Drukker M., Et al., Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes, PLoS One, 3, 10, (2008)
  • [69] Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., Et al., Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts, J Am Coll Cardiol, 50, 19, pp. 1884-1893, (2007)
  • [70] Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H.M., Et al., Tissue engineering of vascularized cardiac muscle from human embryonic stem cells, Circ Res, 100, 2, pp. 263-272, (2007)
123456789